Repair Defect in p21 WAF1/CIP1 -/- human cancer cells

Cancer Res. 1996 May 15;56(10):2250-5.

Abstract

p53 induction and cell cycle arrest occur following DNA damage, possibly to allow repair prior to replication. p21WAF1/CIP1, a cyclin-cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen-interacting protein, is induced by p53 and mediates the cell cycle arrest. To investigate a role for p21 in DNA repair in vivo, we studied the expression of in vitro damaged reporter DNA transfected into p21 +/+ or -/- HCT116 human colon cancer cells. Introduction of UV-damaged or cisplatinum-damaged cytomegalovirus-driven beta-galactosidase reporter DNA into tumor cells revealed a significant decrease (2-5-fold) in reporter expression in p21 -/- versus +/+ cells. In the absence of DNA damage, there was a significant increase (2-3-fold) in the number of 6-TG-resistant colonies derived from p21 -/- versus +/+ cells. Reintroduction of wild-type p21, but not a p21 C-terminal truncation mutant which lacks the proliferating cell nuclear antigen interaction domain, stimulated (2-3-fold) the repair capacity of the p21-deficient cells. We conclude that p21 deficiency is associated with a defect in DNA repair, which could lead to an increased sensitivity of tumor cells to DNA damage.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Cycle / genetics*
  • Cell Division
  • Cisplatin / pharmacology
  • Colonic Neoplasms / pathology*
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / deficiency*
  • Cyclins / genetics
  • Cyclins / physiology
  • DNA Damage
  • DNA Repair / genetics*
  • DNA Replication
  • DNA, Neoplasm / drug effects
  • DNA, Neoplasm / metabolism*
  • DNA, Neoplasm / radiation effects
  • Genes, Reporter / drug effects
  • Genes, Reporter / radiation effects
  • Humans
  • Neoplasm Proteins / deficiency*
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology
  • Proliferating Cell Nuclear Antigen / metabolism
  • Thioguanine / pharmacology
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay
  • Tumor Suppressor Protein p53 / physiology
  • Ultraviolet Rays

Substances

  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • DNA, Neoplasm
  • Neoplasm Proteins
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53
  • Thioguanine
  • Cisplatin